Zymeworks (ZYME): Perceptive Advisors LLC reduced its stake -50K shares
Perceptive Advisors LLC reduced its stake in Zymeworks, per its Q4 2024 13F.
- 2.13M
- Shares reported · -50K vs prior quarter
- 0.86%
- Disclosed portfolio weight
- $31.2M
- Reported value
- Holdings as of
- Dec 31, 2024
- Filed
- Feb 14, 2025
What stands out in this filing
- 2,180,020 shares in Q3 2024, 2,130,020 now (−2.3% in share count).
- Reported at $31.2M, 0.86% of the portfolio value in this 13F filing.
- 5 other tracked managers reported the same kind of change for Q4 2024.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 19, 2024InsiderDirector purchased ~$4.04M of ZYME shares in the open market
- Dec 20, 2024InsiderDirector purchased ~$9.92M of ZYME shares in the open market
- Dec 23, 2024InsiderDirector purchased ~$3.58M of ZYME shares in the open market
- Dec 24, 2024InsiderDirector purchased ~$169K of ZYME shares in the open market
- Dec 26, 2024InsiderDirector purchased ~$240K of ZYME shares in the open market
- Dec 27, 2024InsiderDirector purchased ~$1.47M of ZYME shares in the open market
- Dec 30, 2024InsiderDirector purchased ~$853K of ZYME shares in the open market
- Dec 31, 2024InsiderDirector purchased ~$2.13M of ZYME shares in the open market
- Jan 2, 2025InsiderDirector purchased ~$2.33M of ZYME shares in the open market
- Jan 6, 2025Insider · 3 peopleInsiders: 5 sales (~$1.3M)
- Jan 8, 2025InsiderDirector purchased ~$296K of ZYME shares in the open market
- Jan 10, 2025InsiderDirector purchased ~$2.68M of ZYME shares in the open market
- Jan 13, 2025InsiderDirector purchased ~$993K of ZYME shares in the open market
- Jan 14, 2025InsiderDirector purchased ~$739K of ZYME shares in the open market
- Jan 15, 2025InsiderDirector purchased ~$547K of ZYME shares in the open market
- Jan 16, 2025InsiderDirector purchased ~$1.69M of ZYME shares in the open market
- Jan 17, 2025InsiderDirector purchased ~$274K of ZYME shares in the open market
What came next
- Mar 11, 2025InsiderDirector purchased ~$3.69M of ZYME shares in the open market
- Mar 12, 2025InsiderDirector purchased ~$3.59M of ZYME shares in the open market
- Mar 13, 2025InsiderDirector purchased ~$5.85M of ZYME shares in the open market
- Mar 17, 2025InsiderDirector purchased ~$688K of ZYME shares in the open market
- Mar 18, 2025InsiderDirector purchased ~$1.44M of ZYME shares in the open market
- Mar 19, 2025InsiderDirector purchased ~$737K of ZYME shares in the open market
- Mar 20, 2025InsiderDirector purchased ~$950K of ZYME shares in the open market
- Mar 21, 2025InsiderDirector purchased ~$397K of ZYME shares in the open market
- Mar 24, 2025InsiderDirector purchased ~$297K of ZYME shares in the open market
- Mar 25, 2025InsiderDirector purchased ~$690K of ZYME shares in the open market
- Mar 26, 2025InsiderDirector purchased ~$537K of ZYME shares in the open market
- Mar 31, 2025InsiderDirector purchased ~$52K of ZYME shares in the open market
- Apr 1, 2025InsiderDirector purchased ~$565K of ZYME shares in the open market
- Apr 2, 2025InsiderDirector purchased ~$881K of ZYME shares in the open market
- Apr 3, 2025InsiderDirector purchased ~$1.43M of ZYME shares in the open market
- Apr 4, 2025InsiderDirector purchased ~$2.19M of ZYME shares in the open market
- Apr 16, 2025InsiderDirector purchased ~$826K of ZYME shares in the open market
- Apr 17, 2025InsiderDirector purchased ~$631K of ZYME shares in the open market
- May 15, 2025InsiderDirector purchased ~$566K of ZYME shares in the open market
- May 19, 2025InsiderDirector purchased ~$70K of ZYME shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Zymeworks
For Zymeworks, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ZYME page.
How this filing works
Explore the data
Common questions
What does this filing report about Zymeworks (ZYME) stock?
Perceptive Advisors LLC reduced its stake in Zymeworks, per its Q4 2024 13F. Now 2.13M shares, $31.2M reported value, 0.86% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2024. Filed: Feb 14, 2025.
What stands out in this filing?
2,180,020 shares in Q3 2024, 2,130,020 now (−2.3% in share count). Reported at $31.2M, 0.86% of the portfolio value in this 13F filing. 5 other tracked managers reported the same kind of change for Q4 2024.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Zymeworks recently?
For Zymeworks, OQRO holds 8 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ZYME page.
Does this mean ZYME stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Zymeworks
- SEC Form 144Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 4Nov 16, 2026
- SEC Form 144Nov 13, 2026
Everything OQRO holds on this company is on its ZYME page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
